1-3 of 3
Minna Tanner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer

Mervi Laakso, Minna Tanner, Jonas Nilsson, Tom Wiklund, Björn Erikstein, Pirkko Kellokumpu-Lehtinen, Per Malmström, Nils Wilking, Jonas Bergh, Jorma Isola
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4185–4191.
https://doi.org/10.1158/1078-0432.CCR-06-0353
Published: 20 July 2006
View article titled, Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer
Open the PDF for Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer in another window
Journal Articles

Interlaboratory Comparison of HER-2 Oncogene Amplification as Detected by Chromogenic and Fluorescence in situ Hybridization

Jorma Isola, Minna Tanner, Amanda Forsyth, Timothy G. Cooke, Amanda D. Watters, John M. S. Bartlett
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4793–4798.
https://doi.org/10.1158/1078-0432.CCR-0428-03
Published: 21 July 2004
View article titled, Interlaboratory Comparison of <em>HER-2</em> Oncogene Amplification as Detected by Chromogenic and Fluorescence <em>in situ</em> Hybridization
Open the PDF for Interlaboratory Comparison of <em>HER-2</em> Oncogene Amplification as Detected by Chromogenic and Fluorescence <em>in situ</em> Hybridization in another window
Journal Articles

HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil

Angelo Di Leo, David Gancberg, Denis Larsimont, Minna Tanner, Tero Jarvinen, Ghizlane Rouas, Stella Dolci, Jean-Yves Leroy, Marianne Paesmans, Jorma Isola, Martine J. Piccart
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1107–1116.
Published: 01 May 2002
View article titled, HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil
Open the PDF for HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil in another window